Topical Advisory Panel for section 'Cancer Therapy'
- Molecular Cancer Biology Section
- Cancer Immunology and Immunotherapy Section
- Cancer Biomarkers Section
- Cancer Epidemiology and Prevention Section
- Cancer Pathophysiology Section
- Tumor Microenvironment Section
- Cancer Causes, Screening and Diagnosis Section
- Cancer Therapy Section
- Clinical Research of Cancer Section
- Systematic Review or Meta-Analysis in Cancer Research Section
- Methods and Technologies Development Section
- Cancer Informatics and Big Data Section
- Pediatric Oncology Section
- Infectious Agents and Cancer Section
- Cancer Drug Development Section
- Cancer Metastasis Section
- Transplant Oncology Section
Please see the section webpage for more information on this section.
Members
2. CNR Associate, Signal Transduction Laboratory, Department of Biomedical Sciences, Institute of Genetics and Biophysics "A. Buzzati Traverso", National Research Council, CNR, Via Castellino, 111, Naples, Italy
Interests: angiogenesis; glioblastoma; cancer stem cells; cell migration; cell invasion; HDAC; vasculogenic mimicry; chondrosarcoma; monocytes; tumor-associated macrophages; cell migration inhibitors; tumor microenvironment; metastatic dissemination; breast cancer cell invasion; αv integrin; cancer-associated fibroblasts
Special Issues, Collections and Topics in MDPI journals
Interests: checkpoint inhibition (with special interest in immune related adverse events (irAEs) and response prediction using machine learning) and melanoma
Interests: cancer Immunotherapy; tumor immune evasion; tumor microenvironment; dendritic cells; Wnt/Beta-catenin signaling; Treg; Th17; anti-tumor immunity; nanobodies; Interferons; antibody drug conjugates

Interests: clinical oncology; rare tumors; neuroendocrine tumors; medical oncology; cancer metastasis
Special Issues, Collections and Topics in MDPI journals
Interests: lung cancer; immunotherapy; immune checkpoint inhibitor; surgery; sarcopenia; nutrition
Special Issues, Collections and Topics in MDPI journals
Interests: tumor-driving RAS/SIAH/EGFR/HER2 signaling pathway; K-RAS-driven malignant; SIAH E3 ligase biology; SIAH-interacting proteins and complexes in human cancer; anti-SIAH-based anti-K-RAS/EGFR/HER2 therapy for preclinical and clinical testing; new tumor vulnerabilities (including SIAH) in high-risk, high-grade, relapsed, and multidrug-resistant malignant tumors; validating and verifying tumor-specific, therapy-responsive, and prognostic biomarkers (including SIAH) for FDA approval and clinical application; stratifying patients, identifying chemo-resistant tumor clones, forecasting early tumor relapse, and predicting patient survival in the clinic; developing prognostic and predictive biomarkers to stratify cancer patients in order to optimize the efficacy of current immuno-oncology therapies used in the clinic
Interests: radiation therapy; gastrointestinal cancer; pancreatic cancer; anal cancer; microbiome; stem cell biology
Interests: colorectal cancer; metastasis; translational research; tumour microenvironment; TGF-beta; immunotherapy; organoids; mouse models
Interests: pancreatic cancer; liver cancer; biliary cancer; colorectal cancer; bowel cancer; gastric cancer; robotic surgery; laparoscopic surgery; lymphadenectomy; gastrointestinal stromal tumour; peritoneal carcinomatosis
Special Issues, Collections and Topics in MDPI journals
Interests: immunotherapy; lung cancer
Interests: tumor microenvironment; gene therapy; metabolism; hypoxia; prokaryotic vectors; translational studies

Interests: tumor angiogenesis; autophagy; apoptosis; DNA damage and repair; ovarian cancer; PARP inhibitor; microvasculature
Special Issues, Collections and Topics in MDPI journals
Interests: cancer; checkpoint inhibitors; therapy; breast cancer; immune-checkpoint; pancreatic cancer

Interests: cardio-oncology; heart failure
Special Issues, Collections and Topics in MDPI journals
Interests: colorectal cancer; Advanced Cancer Cachexia; advanced pancreatic cancer
Interests: breast cancer; cancer policy
Interests: radiochemotherapy; head and neck cancer; quality of life; late side effects; recurrent/metastastic head and neck cancer; immunotherapy; palliation
2. Division of Pathology and Cellular Biology, Université de Montréal, Montreal, QC H3C 3J7, Canada
Interests: prostate cancer; intraductal carcinoma of the prostate; biomarkers; Raman spectroscopy; histology
Interests: colorectal surgery; rectal cancer; locally recurrent rectal cancer; multivisceral resection; peritoneal metastasis; HIPEC; medical ethics; quality of life
Special Issues, Collections and Topics in MDPI journals
Interests: oesophageal cancer; tumour microenvironment; tumour ecosystems; predicting response to treatment; machine learning and AI in surgery
Special Issues, Collections and Topics in MDPI journals
Interests: hereditary gastrointestinal tumors
Interests: adipocyte; cancer; pancreas; obesity; adiponectin; leptin; SHP-2; adipokine; microenvironment; MAPK
Special Issues, Collections and Topics in MDPI journals
Interests: BCL-2 family of proteins in cancer; cell death; apoptosis; mitochondria; glutamine metabolism
Interests: DNA double strand break repair; Homologous recombination; DNA end resection; SWI/SNF chromatin remodelers; senescence; apoptosis; chemotherapy; radiotherapy
Interests: neuroanatomy; neuro-oncology; awake craniotomy; intraoperative neuro-monitoring; brain mapping; tractography; transcranial magnetic stimulation
Special Issues, Collections and Topics in MDPI journals
Interests: translational research; castrate-resistant prostate cancer; stem cell and CRPC; cancer cell metabolism; data science; cell signaling; immunotherapy
Special Issues, Collections and Topics in MDPI journals
Interests: pleural mesothelioma; oncogenes; inflammatory cytokines; robotic surgery; liquid biopsy; lung transplantation; immunemodulation; epigenomics; lung cancer
Special Issues, Collections and Topics in MDPI journals
Interests: particle radiation (investigating the relative biological effectiveness (RBE) in mono/co-cultures, organotypic models, organ slice cultures and animal models); experimental radiotherapy (investigating in established and primary tumor models in vivo/ex vivo, biomarkers for radiosensitivity, tumor micromilieu, and combined radio-oncological therapy modalities
Interests: the interactions between radiation and abnormal metabolism in glioblastoma
Interests: colorectal disease; surgery